Central Europe and the Baltics vs Turkmenistan: Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and over time
- Central Europe and the Baltics
- Turkmenistan
How they compare
Turkmenistan currently reports 21.4% against 12.4% in Central Europe and the Baltics, a difference of 9.0%.
That makes Turkmenistan's figure about 1.7 times Central Europe and the Baltics's.
Across all 22 years both countries report, Turkmenistan has been ahead every year.
Central Europe and the Baltics ranks 39th and Turkmenistan ranks 42nd of 47 groups.
Turkmenistan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Central Europe and the Baltics | Turkmenistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 15.9% | 26.7% | 10.9% | Turkmenistan |
| 2010s | 13.2% | 22.3% | 9.1% | Turkmenistan |
| 2020s | 12.4% | 21.4% | 9.0% | Turkmenistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher mortality from cvd, cancer, diabetes or crd between exact ages 30 and, Central Europe and the Baltics or Turkmenistan?
- Turkmenistan, at 21.4% against 12.4% in Central Europe and the Baltics as of 2021.
- What is the difference in mortality from cvd, cancer, diabetes or crd between exact ages 30 and between Central Europe and the Baltics and Turkmenistan?
- 9.0%, with Turkmenistan ahead.
- How many years of comparable data are there for Central Europe and the Baltics and Turkmenistan?
- 22 years are reported by both, from 2000 to 2021.
- How do Central Europe and the Baltics and Turkmenistan rank globally for mortality from cvd, cancer, diabetes or crd between exact ages 30 and?
- Central Europe and the Baltics ranks 39th and Turkmenistan ranks 42nd of 47 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO), published as Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).